Keyphrases
Cellular Response
100%
Brain Tumor
100%
Response to Treatment
100%
Medulloblastoma
100%
Pediatric Glioma
100%
G207
100%
Viral Immunotherapy
100%
Cell Surface Receptor
33%
Differentially Expressed Genes
33%
Lethal Dose
33%
LANCL2
33%
Chimera
16%
RNA Sequencing (RNA-seq)
16%
Molecular Mechanism
16%
Clinical Trials
16%
Response Pattern
16%
Pediatric
16%
Control Cell
16%
Receptor Expression
16%
Vascular Endothelial Growth Factor
16%
Single Positive
16%
Primary Brain Tumor
16%
Pediatric Brain Tumor
16%
Gene Set Enrichment Analysis
16%
Multiplicity of Infection
16%
Positive-strand RNA Virus
16%
High-grade Glioma
16%
ADAMTS
16%
CD155
16%
Rhinovirus
16%
Inverse Correlation
16%
Biomarkers of Response
16%
Putative Biomarkers
16%
Glioma Cell Lines
16%
EIF4G1
16%
Polio
16%
Double-stranded DNA Virus
16%
RBM3
16%
GPSM2
16%
GDAP1
16%
Medicine and Dentistry
Pediatrics
100%
Immunotherapy
100%
Ganglioglioma
100%
Intracranial Tumor
100%
Medulloblastoma
100%
G 207
100%
Glioma Cell Line
33%
Biological Marker
16%
RNA Sequence
16%
Infection
16%
Clinical Trial
16%
Receptor
16%
Brain Cancer
16%
Receptor Expression
16%
Pediatric Brain Tumor
16%
Rhinovirus
16%
Positive-Strand RNA Virus
16%
Poliomyelitis
16%
Medulloblastoma Cell Line
16%
Double-Stranded DNA Virus
16%
Pharmacology, Toxicology and Pharmaceutical Science
Immunotherapy
100%
Glioma
100%
Medulloblastoma
100%
Intracranial Tumor
100%
G 207
100%
Receptor
33%
Infection
16%
Clinical Trial
16%
Biological Marker
16%
RNA-Sequencing
16%
Brain Cancer
16%
Rhinovirus
16%
Positive-Strand RNA Virus
16%
Poliomyelitis
16%
Double-Stranded DNA Virus
16%
Neuroscience
Immunotherapy
100%
Medulloblastoma
100%
Intracranial Tumor
100%
Cell Line
66%
DNA Virus
33%
Receptor Expression
33%
RNA Sequence
33%
Double Stranded DNA
33%
RNA Virus
33%
Pediatric Brain Tumor
33%
Rhinovirus
33%
Receptor
33%
CD155
33%
Biochemistry, Genetics and Molecular Biology
GCLM
100%
RNA Sequence
50%
Clinical Trial
50%
ADAMTS1
50%
Positive-Strand RNA Virus
50%
Rhinovirus
50%
Double-Stranded DNA Virus
50%
CD155
50%
GDAP1
50%
Immunology and Microbiology
Immunotherapy
100%
G 207
100%
Glioma Cell Line
33%
RNA Sequence
16%
Multiplicity of Infection
16%
Positive-Strand RNA Virus
16%
CD155
16%
Rhinovirus
16%
Double-Stranded DNA Virus
16%
Medulloblastoma Cell Line
16%